Patent ID: 11903996
Assignee: nan
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 14:
15. A method for ameliorating effects caused by a disease comprising delivering an amount of the modified C3 protein according to claim 1 effective to deplete complement, wherein the disease is selected from the group consisting of: Neuromyelitis Optica, Multiple Sclerosis, Myasthenia Gravis, Rheumatoid arthritis, wet and dry Age-Related Macular Degeneration, Hemoglobin Urinary Syndrome, Paroxysmal Nocturnal Hemoglobinemia, Inflammatory Bowel Disease, Crohn's Disease, Alzheimer's disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis, Familial Mediterranean Fever, Dengue Fever, Cardiac or any Reperfusion Injury, Gout, Dense Deposit Disease, C3 Glomerulonephritis, Neuropathic Pain, and Inflammatory Pain.